Non-Steroidal Alzheimer’s Nasal Spray®
Non-Steroidal Alzheimer’s Nasal Spray (Patented Rx Technology)
- Alzheimer’s Nasal Spray – Patented Rx Technology
- In Alzheimer’s Patients, our Patented Non-Steroidal Alzheimer’s Nasal Spray for Adults was shown to increase SaO2 levels and eliminated hypoxemia.
Non-Steroidal COPD Nasal Spray®
Non-Steroidal COPD Nasal Spray (Patented Rx Technology)
- Non-Steroidal COPD Nasal Spray for Children/Adults has been shown to help relieve clinical symptoms and improve lung function in US Phase I/II/III Clinical Trials
- Completed US Phase I and Phase II Clinical Trials for COPD/Asthma/Cystic Fibrosis and completed a Phase III Clinical Trial for Interstitial Lung Disease (ILD)
- Received US FDA Orphan Drug Designation in 2005 for Cystic Fibrosis (CF) and Interstitial Lung Disease (ILD)
- Patented Rx Technology also included an Oral Spray version
Unmet Needs Breathing Treatment-Diabetic-Hypertensive Patients®
Unmet Needs Breathing Treatment for Diabetic and Hypertensive Patients (Patented Rx Technology)
- N115 Nasal Spray is a safe, non-steroidal anti-inflammatory formula to treat any or all their sinus or lung respiratory problems.
- Patients with Diabetes and/or Hypertension should not take Steroid based Sprays because they are counter-indicated with the drugs taken for Diabetes and Hypertension treatment.
SMOKING CESSATION ORAL SPRAY®
Smoking Cessation Oral Spray (Patented Rx Technology)
- Smoking Cessation Oral Spray – Patented Rx Technology
- Smoking Cessation Oral Spray for Adults was shown to help relieve the need to smoke and Improve lung functions in a Clinical Trial.
Pulmonary Fibrosis Treatment®
Pulmonary Fibrosis Treatment (Patented Rx Technology)
- Patented Rx Technology
- In a Phase III Clinical Trial, in Patients with Pulmonary Fibrosis, there was a statistically and clinically significant improvement in all lung functions, compared to baseline, including an increase in FEV-1, SaO2, FVC, FEV-1/FVC ratios (from 52% to 86%) and a decrease in hypoxemia, along with a reduction in coughing and fatigue.
- Non-Steroidal COPD/Pulmonary Fibrosis Nasal Spray that has shown to relieve clinical symptoms and improve lung functions, decrease coughing, and improve FEV-1, FVC, SaO2, and increase FEV-1/FVC ratios from 52% to 86% in all patients with Idiopathic Pulmonary Fibrosis (IPF).
- Completed US Phase I, Phase II, Phase III Clinical Trials for COPD Pulmonary Fibrosis/Interstitial Lung Disease (ILD).
- Submitted NDA to the FDA defining Medical Endpoints for the NDA Marketing Application.
- Received US FDA Orphan Drug Designation in 2005 for Cystic Fibrosis (CF) and Interstitial Lung Disease (ILD)
Northcell Pharma
We are driven with a passion for creating better OTC Products and Drugs that help Patients with symptoms relief and improves their quality of life.
For Questions Contact Us
Northcell Pharma
North Cell Pharmaceutical Worldwide Patented Skin Resuscitation Factor® or SRF® SRF®greatly enhances healing with its use in our Drug Free OTC Skincare and OTC Post Laser Aftercare Products.SRF® is the key component in our Rx Drug Pipeline for Eczema (Atopic Dermatitis) and Topical Melanoma Lotions, along with an Injectable for Inoperable Tumors.
Investor Relations
North Cell Pharmaceutical is a private Biotech in Flemington, New Jersey that specializes in Patented next generation, faster/better healing technology for Skincare and Post Laser Aftercare products, Pet Products, as well as an Rx Drug Pipeline for Eczema, Topical Melanoma, and Injectables for Inoperable Tumors.
Drug & Product Pipeline
We are driven with a passion for creating better OTC Products and Drugs that help Patients with symptoms relief and improves their quality of life.
New Products and Research
Please see our Drug Pipeline for Details.
Northcell Pharma in the News
For the latest news on our research and development of new products, reviews and more.
WHO WE ARE
North Cell Pharmaceutical is a private Biotech in Flemington, New Jersey that specializes in Patented next generation, faster/better healing technology for Skincare and Post Laser Aftercare products, Pet Products, as well as an Rx Drug Pipeline for Eczema, Topical Melanoma, and Injectables for Inoperable Tumors.
SRF® (Skin Resuscitation Factor®) is specifically developed by leading dermatologists to promote rapid healing of damaged skin, and reduce inflammation, redness, dryness, heat, swelling, and promote coolness. Results based on (10) USA Human Clinical Studies.
Fourteen Clinical Studies were completed on damaged skin including dry cracked skin, laser treated skin and infected wounds. As an example, twelve of the blinded studies were conducted by David McDaniel, MD. the original researcher on the use of lasers to treat skin.
Experience Counts
Dr. Alain Martin (Rutgers Graduate – Robert Wood Johnson Ph.D – also has multiple Masters Degrees including Genetics invented Advanced Neosporin, Neosporin Cold Sore Treatment, Advanced Therapy Lubriderm, Rx Rezulin (Rx Drug for Type II Diabetes), Topical Skin and Melanoma Lotions
